4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-020382
Chief Medical Officer sold 866 shares at $8.06 ($6,980)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rottinghaus Scott T. Chief Medical Officer | 2024-12-06 | Sale 10b5-1 | −866 | $8.06 | $6,980 | 17,918 | D: show line 1 in the form |
| Open-market sales · 866 sh · avg $8.06 · $6,980 | |||||||
Loading xslF345X05/form4.xml…